VERISOL®
+15% Skin elasticity¹
Proksch E, et al. Skin Pharmacol Physiol 2014;27(1):47–55
Double-blind, placebo-controlled study with 69 women aged 35 to 55 years. The participants received 2.5g VERISOL® daily for 8 weeks. There was a statistically significant increase in skin elasticity, with the effect being most pronounced in women over 50. It is noteworthy that the improvement persisted even 4 weeks after the end of supplementation.

VERISOL®
–32% wrinkle depth²
Proksch E, et al. Skin Pharmacol Physiol 2014;27(3):113–119
Double-blind, placebo-controlled study with 114 women aged 45 to 65 years. After 8 weeks of daily intake of 2.5g VERISOL®, the volume of eye wrinkles was reduced by up to 32%. Skin biopsies confirmed a 65% increase in procollagen type I and an 18% increase in elastin synthesis – proof that the peptides act at the cellular level.

VERISOL®
+31% hair follicle growth³
Oesser S, et al. Nutrafoods 2020;1:134–138
Randomized, placebo-controlled study with 44 healthy women aged 39 to 75 years over a period of 16 weeks. The VERISOL® group showed a statistically significant increase in hair thickness (+1.93 µm), while the placebo group showed a slight decrease. In-vitro tests confirmed a 31% increase in hair follicle cell proliferation rate, demonstrating that VERISOL® directly stimulates hair metabolism.

VERISOL®
–11% cellulite⁴
Schunck M, et al. J Med Food 2015;18:1340–1348
Double-blind, placebo-controlled study with 105 women aged 24 to 50 years with moderate cellulite. After 6 months of daily intake of 2.5g VERISOL®, the participants showed a statistically significant reduction in the degree of cellulite, a reduction in skin rippling and a 9% increase in skin density compared to placebo, demonstrating that the peptides restore the structure of the skin connective tissue.

VERISOL®
–42% nail fragility⁵
Hexsel D, et al. J Cosmet Dermatol 2017;16(1):1–7
Clinical study with 25 participants who took 2.5g VERISOL® daily for 24 weeks. The nail growth rate increased by 12% and the incidence of nail breakage decreased by 42%. 88% of participants reported an improvement just 4 weeks after treatment, and 80% were completely satisfied with the results.

FORTIGEL®
–42% less joint pain⁶
Zdzieblik D, et al. Nutrients 2021;13(2):523
Randomized, double-blind, placebo-controlled study with 180 physically active men and women aged 18 to 30 years with exercise-induced knee pain. After 12 weeks of daily intake of 5g FORTIGEL® participants showed a statistically significant reduction in activity-induced joint pain compared to placebo.

FORTIGEL®
+12% bone mineral density⁷
Zdzieblik D, et al. J Bone Metab 2021;28(3):207–213
This is a follow-up study to the original study from 2018. 131 postmenopausal women (mean age 64 years) with age-related BMD reduction participated in the first randomized, double-blind, placebo-controlled study. After 12 months of daily intake of 5g collagen peptides, the BMD of the spine and femoral neck increased significantly compared to placebo, and the bone formation marker P1NP was also significantly increased. The 4-year follow-up confirmed the sustained benefits.

VERISOL®
Skin hydration, elasticity and wrinkles
Proksch E, Zdzieblik D, Oesser S. Cosmetics 2025;12(2):79
Double-blind, placebo-controlled study with 66 women aged 35 to 55 years. The participants received 2.5g VERISOL® made from bovine collagen or placebo daily for 8 weeks. Skin hydration, elasticity and the volume of eye wrinkles improved significantly after 4 weeks, with the effect being even more pronounced after 8 weeks. Wrinkles decreased by an average of 25% and skin elasticity improved by 9%. In-vitro experiments confirmed that VERISOL® stimulates the biosynthesis of type I collagen, elastin and proteoglycans. This is the first study to confirm the moisturizing effect of VERISOL® in addition to its known effects on elasticity and wrinkle reduction.

FORTIGEL®
Synthesis of ligament and tendon matrix
Praet SF, et al. (In-vitro study)
Laboratory study showing that FORTIGEL® significantly stimulates the biosynthesis of ligament and tendon matrix molecules. RNA expression and the synthesis of collagen types I and III increased by 1.2 to 2.4 times compared to untreated controls. Proteoglycan synthesis (versican, decorin) also increased in both Achilles tendon and ligament fibroblasts.

FORTIGEL®
Synthesis of ligament and tendon matrix (in vitro)
Schunck M, Oesser S. J Int Soc Sports Nutr 2013;10(Suppl 1):P23
In-vitro laboratory study on primary human fibroblasts from ligaments and Achilles tendons. The treatment with FORTIGEL® led to statistically significant increases: Type I and III collagen synthesis increased 1.2- to 2.4-fold, proteoglycan synthesis (versican, decorin) increased in both tissue types and elastin biosynthesis increased by approximately 50%. Importantly, the expression of matrix metalloproteinases was downregulated, suggesting that FORTIGEL® both builds new tissue and protects against degradation. The authors concluded that FORTIGEL® is a promising option for the treatment and prevention of tendinopathies and may reduce the risk of injury and rupture.

FORTIGEL®
Knee osteoarthritis (with Fucoidan)
Martin-Martin LS, et al. Clin Res Trials 2016
Randomized multicenter study with 126 participants aged 40 to 65 years with mild to moderate knee osteoarthritis (Kellgren-Lawrence grade 2–3). After 12 weeks (not 3 months) of daily intake of 10g FORTIGEL® + 100mg fucoidan, participants showed a significant reduction in VAS pain scores and Lequesne's algo-function index.

FORTIGEL®
Joint pain in athletes (pioneering study)
Clark KL, et al. Curr Med Res Opin 2008;24(5):1485–1496
Randomized, double-blind, placebo-controlled study with 147 subjects (97 completed the study and were statistically analyzed) at Penn State University. Participants received 10g FORTIGEL® or placebo daily for 24 weeks. Six parameters showed a statistically significant improvement over placebo, with more pronounced effects in the knee subgroup analysis.

FORTIGEL®
Cartilage regeneration in knee osteoarthritis (MRI study)
McAlindon TE et al. Osteoarthritis Cartilage 2011;19(4):399–405
Randomized, placebo-controlled, double-blind pilot study, conducted at Tufts Medical Center/Harvard Medical School with 30 participants with knee osteoarthritis. Participants received 10g FORTIGEL® or placebo daily for 48 weeks. Using advanced dGEMRIC MRI imaging, the FORTIGEL® group showed a statistically significant increase in proteoglycan density in knee cartilage (medial tibial region +29 ms, lateral tibia +41 ms), while the placebo group showed a decrease. This was the first human study to demonstrate that oral collagen peptides directly regenerate cartilage structure.

FORTIGEL®
Activity-related knee pain in young adults
Zdzieblik D, et al. Appl Physiol Nutr Metab 2017;42(6):588–595
Randomized, double-blind, placebo-controlled study with 139 athletes with functional knee problems (no diagnosed joint disease). After 12 weeks with 5g FORTIGEL® daily, the participants showed a statistically significant reduction in activity-induced knee pain compared to placebo. The use of additional treatments (painkillers, physiotherapy) was also significantly reduced.

FORTIGEL®
Functional joint pain in everyday lifeSchulze C, et al. Nutrients 2024;16(11):1646
Randomized, placebo-controlled study with 182 healthy adults who suffered from knee and hip pain during everyday activities. After 12 weeks of taking 5g of FORTIGEL® daily, participants showed a significant reduction in pain at rest, when walking, climbing stairs and kneeling. This confirms that the benefits of FORTIGEL® extend beyond athletes to everyday joint pain.

VERISOL®
+15% Skin elasticity¹
Proksch E, et al. Skin Pharmacol Physiol 2014;27(1):47–55
Double-blind, placebo-controlled study with 69 women aged 35 to 55 years. The participants received 2.5g VERISOL® daily for 8 weeks. There was a statistically significant increase in skin elasticity, with the effect being most pronounced in women over 50. It is noteworthy that the improvement persisted even 4 weeks after the end of supplementation.

VERISOL®
–32% wrinkle depth²
Proksch E, et al. Skin Pharmacol Physiol 2014;27(3):113–119
Double-blind, placebo-controlled study with 114 women aged 45 to 65 years. After 8 weeks of daily intake of 2.5g VERISOL®, the volume of eye wrinkles was reduced by up to 32%. Skin biopsies confirmed a 65% increase in procollagen type I and an 18% increase in elastin synthesis – proof that the peptides act at the cellular level.

VERISOL®
+31% hair follicle growth³
Oesser S, et al. Nutrafoods 2020;1:134–138
Randomized, placebo-controlled study with 44 healthy women aged 39 to 75 years over a period of 16 weeks. The VERISOL® group showed a statistically significant increase in hair thickness (+1.93 µm), while the placebo group showed a slight decrease. In-vitro tests confirmed a 31% increase in hair follicle cell proliferation rate, demonstrating that VERISOL® directly stimulates hair metabolism.

VERISOL®
–11% cellulite⁴
Schunck M, et al. J Med Food 2015;18:1340–1348
Double-blind, placebo-controlled study with 105 women aged 24 to 50 years with moderate cellulite. After 6 months of daily intake of 2.5g VERISOL®, the participants showed a statistically significant reduction in the degree of cellulite, a reduction in skin rippling and a 9% increase in skin density compared to placebo, demonstrating that the peptides restore the structure of the skin connective tissue.

VERISOL®
–42% nail fragility⁵
Hexsel D, et al. J Cosmet Dermatol 2017;16(1):1–7
Clinical study with 25 participants who took 2.5g VERISOL® daily for 24 weeks. The nail growth rate increased by 12% and the incidence of nail breakage decreased by 42%. 88% of participants reported an improvement just 4 weeks after treatment, and 80% were completely satisfied with the results.

FORTIGEL®
–42% less joint pain⁶
Zdzieblik D, et al. Nutrients 2021;13(2):523
Randomized, double-blind, placebo-controlled study with 180 physically active men and women aged 18 to 30 years with exercise-induced knee pain. After 12 weeks of daily intake of 5g FORTIGEL® showed a statistically significant reduction in activity-induced joint pain compared to placebo.

FORTIGEL®
+12% bone mineral density⁷
Zdzieblik D, et al. J Bone Metab 2021;28(3):207–213
This is a follow-up study to the original study from 2018. 131 postmenopausal women (mean age 64 years) with age-related BMD reduction participated in the first randomized, double-blind, placebo-controlled study. After 12 months of daily intake of 5g collagen peptides, the BMD of the spine and femoral neck increased significantly compared to placebo, and the bone formation marker P1NP was also significantly increased. The 4-year follow-up confirmed the sustained benefits.

VERISOL®
Skin hydration, elasticity and wrinkles
Proksch E, Zdzieblik D, Oesser S. Cosmetics 2025;12(2):79
Double-blind, placebo-controlled study with 66 women aged 35 to 55 years. The participants received 2.5g VERISOL® made from bovine collagen or placebo daily for 8 weeks. Skin hydration, elasticity and the volume of eye wrinkles improved significantly after 4 weeks, with the effect being even more pronounced after 8 weeks. Wrinkles decreased by an average of 25% and skin elasticity improved by 9%. In-vitro experiments confirmed that VERISOL® stimulates the biosynthesis of type I collagen, elastin and proteoglycans. This is the first study to confirm the moisturizing effect of VERISOL® in addition to its known effects on elasticity and wrinkle reduction.

FORTIGEL®
Synthesis of ligament and tendon matrix
Praet SF, et al. (In-vitro study)
Laboratory study showing that FORTIGEL® significantly stimulates the biosynthesis of ligament and tendon matrix molecules. RNA expression and the synthesis of collagen types I and III increased by 1.2 to 2.4 times compared to untreated controls. Proteoglycan synthesis (versican, decorin) also increased in both Achilles tendon and ligament fibroblasts.

FORTIGEL®
Synthesis of ligament and tendon matrix (in vitro)
Schunck M, Oesser S. J Int Soc Sports Nutr 2013;10(Suppl 1):P23
In-vitro laboratory study on primary human fibroblasts from ligaments and Achilles tendons. The treatment with FORTIGEL® led to statistically significant increases: The synthesis of collagen types I and III increased by 1.2 to 2.4 times, the proteoglycan synthesis (versican, decorin) increased in both tissue types and the elastin biosynthesis increased by approximately 50%. Importantly, the expression of matrix metalloproteinases was downregulated, suggesting that FORTIGEL® both builds new tissue and protects against degradation. The authors concluded that FORTIGEL® is a promising option for the treatment and prevention of tendinopathies and may reduce the risk of injury and rupture.

FORTIGEL®
Knee osteoarthritis (with Fucoidan)
Martin-Martin LS, et al. Clin Res Trials 2016
Randomized multicenter study with 126 participants aged 40 to 65 years with mild to moderate knee osteoarthritis (Kellgren-Lawrence grade 2–3). After 12 weeks (not 3 months) of daily intake of 10g FORTIGEL® + 100mg fucoidan, participants showed a significant reduction in VAS pain scores and Lequesne's algo-function index.

FORTIGEL®
Joint pain in athletes (pioneering study)
Clark KL, et al. Curr Med Res Opin 2008;24(5):1485–1496
Randomized, double-blind, placebo-controlled study with 147 subjects (97 completed the study and were statistically analyzed) at Penn State University. The participants received 10g FORTIGEL® or placebo daily for 24 weeks. Six parameters showed a statistically significant improvement over placebo, with more pronounced effects in the knee subgroup analysis.

FORTIGEL®
Cartilage regeneration in knee osteoarthritis (MRI study)
McAlindon TE et al. Osteoarthritis Cartilage 2011;19(4):399–405
Randomized, placebocontrolled, double-blind pilot study, conducted at Tufts Medical Center/Harvard Medical School with 30 participants with knee osteoarthritis. The participants received 10g FORTIGEL® or placebo daily for 48 weeks. Using advanced dGEMRIC MRI imaging, the FORTIGEL® group showed a statistically significant increase in proteoglycan density in knee cartilage (medial tibial region +29 ms, lateral tibia +41 ms), while the placebo group showed a decrease. This was the first human study to demonstrate that oral collagen peptides directly regenerate cartilage structure.

FORTIGEL®
Activity-related knee pain in young adults
Zdzieblik D, et al. Appl Physiol Nutr Metab 2017;42(6):588–595
Randomized, double-blind, placebo-controlled study with 139 athletes with functional knee problems (no diagnosed joint disease). After 12 weeks with 5g FORTIGEL® daily, the participants showed a statistically significant reduction in activity-related knee pain compared to placebo. The use of additional treatments (painkillers, physiotherapy) was also significantly reduced.

FORTIGEL®
Functional joint pain in everyday life
Schulze C, et al. Nutrients 2024;16(11):1646
Randomized, placebo-controlled study with 182 healthy adults who suffered from knee and hip pain during everyday activities. After 12 weeks of taking 5g of FORTIGEL® daily, participants showed a significant reduction in pain at rest, when walking, climbing stairs and kneeling. This confirms that the benefits of FORTIGEL® extend beyond athletes to everyday joint pain.

VERISOL®
–32% wrinkle depth
Proksch E, et al. Skin Pharmacol Physiol 2014;27(3):113–119
Double-blind, placebo-controlled study with 114 women aged 45 to 65 years. After 8 weeks of daily intake of 2.5g VERISOL®, the volume of eye wrinkles was reduced by up to 32%. Skin biopsies confirmed a 65% increase in procollagen type I and an 18% increase in elastin synthesis – proof that the peptides act at the cellular level.

Cynatine® HNS
+30% skin hydration | –34% hair loss | –88% nail breakage²
Beer C, et al. Scientific World Journal 2014; Article ID 641723
Two randomized, double-blind, placebo-controlled studies with 50 women each receiving 500mg of Cynatine® HNS daily for 90 days. The results showed: 46.6% less hair loss, 9.2% improved hair growth cycle, 87.5% improved hair shine (compared to 16.7% with placebo), 30%+ more skin hydration, 17% improved skin elasticity (while placebo lost 4.6%) and 87.5% improved nail resistance (compared to 28.5% with placebo).

VERISOL®
–11% cellulite³
Schunck M, et al. J Med Food 2015;18:1340–1348
Double-blind, placebo-controlled study with 105 women aged 24 to 50 years with moderate cellulite. After 6 months of daily intake of 2.5g VERISOL®, the participants showed a statistically significant reduction in the degree of cellulite.

SkinAx²™
–19% dark circles | +26% radiance | –19% redness | –21% spots⁴
Dumoulin M, et al. Clin Cosmet Investig Dermatol 2016;9:315–324
Clinical study under dermatological supervision with 35 women aged 40 to 70 with a dull complexion. The participants received 150 mg SkinAx²™ daily for two months. Using both objective (cutometer, sensory assessment) and subjective methods, 82% of women achieved a more even complexion and brighter skin – with significant improvements in color, contrast and blemishes. Two out of three women said they looked better after taking the supplement.

VERISOL®
+15% skin elasticity
Proksch E, et al. Skin Pharmacol Physiol 2014;27(1):47–55
Double-blind, placebo-controlled study with 69 women aged 35 to 55 years. The participants received 2.5g VERISOL® daily for 8 weeks. There was a statistically significant increase in skin elasticity – with the effect being most pronounced in women over 50. It is noteworthy that the improvement persisted even 4 weeks after the end of the supplementation.

VERISOL®
Skin hydration, elasticity and wrinkles
Proksch E, Zdzieblik D, Oesser S. Cosmetics 2025;12(2):79
Double-blind, placebo-controlled study with 66 women aged 35 to 55 years. The participants received 2.5g of VERISOL® made from bovine collagen or a placebo daily for 8 weeks. Skin hydration, elasticity and the volume of eye wrinkles improved significantly after 4 weeks, with the effect being even more pronounced after 8 weeks. Wrinkles decreased by an average of 25% and skin elasticity improved by 9%. In-vitro experiments confirmed that VERISOL® stimulates the biosynthesis of type I collagen, elastin and proteoglycans. This is the first study to confirm the moisturizing effect of VERISOL® in addition to its known effects on elasticity and wrinkle reduction.

VERISOL®
+31% hair follicle growth
Oesser S, et al. Nutrafoods 2020;1:134–138
Randomized, placebo-controlled study with 44 healthy women aged 39 to 75 years over a period of 16 weeks. The VERISOL® group showed a statistically significant increase in hair thickness (+1.93 µm), while the placebo group showed a slight decrease. In-vitro tests confirmed a 31% increase in the proliferation rate of hair follicle cells, showing that VERISOL® directly stimulates hair metabolism.

Cynatine®
HNS 50% improvement in skin firmness compared to 8.3% with placebo
Beer C, et al. Int J Cosmet Sci 2014;36(1):22–30
Randomized, double-blind, placebo-controlled study with 50 women. The active group (n = 25) received 500mg Cynatine® HNS-Keratin plus vitamins and minerals daily for 90 days. The endpoints were skin hydration, elasticity, wrinkle reduction, compactness and appearance. The results showed statistically significant improvements in all skin parameters – including increased skin hydration (92% vs. 8% placebo), improved elasticity (while the placebo group lost 4.6% elasticity), a 50% improvement in skin firmness (vs. 8.3% placebo) and a 19.7% improvement in skin protein content.

VERISOL®
–42% Nail brittlenessHexsel D, et al. J Cosmet Dermatol 2017;16(1):1–7
Clinical study with 25 participants who took 2.5g VERISOL® daily for 24 weeks. The nail growth rate increased by 12% and the incidence of nail breakage decreased by 42%. 88% of participants reported an improvement just 4 weeks after treatment and 80% were completely satisfied with the results.

Ceratiq®
+21 skin hydration | –18% wrinkle depth¹
Boisnic S, et al. J Cosmet Dermatol. Dec 2019;18(6):2027–2036.
Randomized, double-blind, placebo-controlled study with 64 women (average age 55.8 years) who received 350mg CERATIQ daily for 12 weeks. The results showed: significantly improved facial skin hydration from week 4, a reduction in the Lemperle wrinkle score by 1 grade by week 12, improved skin radiance and reduced roughness. 95% of subjects showed increased skin hydration compared to placebo.

CoQ10Vital®
+70% skin smoothness | –25% loss of elasticity | 6-fold bioavailability²
Žmitek K, et al. Biofactors 2017;43(1):132–140
Randomized, double-blind, placebo-controlled study with 33 healthy participants who received 50mg or 150mg CoQ10 (Q10Vital®) daily for 12 weeks. The results showed: 70–82% improvement in skin smoothness (blinded expert assessment), significant reduction in wrinkles and microrelief lines, and prevention of seasonal loss of elasticity (placebo lost ~25% elasticity, while CoQ10 groups maintained elasticity). Both doses were effective. Self-assessment also showed improved skin firmness.

SkinAx²™
+26% skin radiance | –19% dark circles | +13% even skin tone | –19% redness | –21% spots³
Dumoulin M, et al. Clin Cosmet Investig Dermatol 2016;9:315–324
Clinical study under dermatological control with 35 women aged 40 to 70 with a dull complexion. The participants received 150mg SkinAx²™ daily for 2 months. Using both objective (cutometer, sensory assessment) and subjective methods, 82% of women achieved a more even complexion and brighter skin – with significant improvements in color, contrast and imperfections. Two out of three women said they looked better after taking the supplement.

Theracurcumin ®
76% clinical efficacy | Reduced joint pain and stiffness | 27-fold bioavailability⁴
Nakagawa Y, et al. Clin Med Insights Arthritis Musculoskelet Disord. 2020;13:1179544120948471.
A 6-month prospective study of 45 patients with knee osteoarthritis who received Theracurmin® (180mg curcumin/day). The results showed that 76% of patients experienced clinically significant improvements in pain and joint function. VAS pain scores, JKOM scores and JOA scores all improved significantly from baseline (p <0.05). Clinical benefits occurred within 1–2 months and persisted for 6 months. Theracurmin®® has a 27-fold higher bioavailability than conventional curcumin powder. No significant side effects were observed.

R-Alpha Lipoic Acid (bioenhanced)
–25% oxidative stress | +22% antioxidant activity⁵
Bobe G, et al. J Nutr. 2020;150(9):2336–2345.
Randomized, double-blind, placebo-controlled study of 81 adults who received 600mg of R-lipoic acid daily for 24 weeks. The results showed: 25% reduction in F₂ isoprostanes (marker for oxidative stress), 22% increase in HMOX1 antioxidant gene expression, 10.1% reduction in leukocytes in the blood and 7.4% reduction in the inflammation marker ICAM-1.

Theracurcumin®
Improvement of knee osteoarthritis
Nakagawa Y, et al. J Orthop Sci. 2014.
Randomized, double-blind, placebo-controlled study with 50 patients with knee osteoarthritis. Theracurmin significantly reduced VAS scores for knee pain after 8 weeks compared to placebo (in patients with a baseline score of >0.15) and significantly reduced celecoxib dependence without serious adverse events.

Ceratiq®
Significantly improved skin hydration
Guillou S, et al. Int J Cosmet Sci 2011;33(2):138–143
Double-blind, randomized, placebo-controlled study with 51 women aged 20 to 63 years with dry to very dry skin. The participants received 350mg of wheat extract oil (rich in ceramides and digalactosyl diglycerides) daily for 3 months. Skin hydration on arms and legs was significantly increased compared to placebo. 95% of women in the treatment group showed increased skin hydration. Skin dryness, roughness and redness were reduced. The product was well tolerated and there were no side effects.

Astaxanthin (AstaReal®)
Prevents skin ageing | Protects moisture and elasticity
Tominaga K, et al. J Clin Biochem Nutr. 2017.
Randomized, double-blind, placebo-controlled study of 65 healthy women who received 6mg or 12mg of AstaReal astaxanthin daily for 16 weeks. Results showed that wrinkle parameters and skin hydration worsened significantly in the placebo group but were maintained in the astaxanthin groups, while astaxanthin suppressed UVB-induced IL-1α and MMP-1 secretion and protected the skin from seasonal deterioration.

Astaxanthin (AstaReal®)
Improved skin elasticity and fine lines | Increased skin hydration and smoothness
Yamashita E. Carotenoid Science. 2006;10:91–95.
Randomized, double-blind, placebo-controlled study in 49 healthy adult women (45–50 years) who received oral astaxanthin (4mg/day) for 6 weeks. The results showed a significant improvement in skin elasticity and fine lines/wrinkles as assessed by dermatology, an increase in skin hydration levels as measured by instruments and improvements in skin texture/smoothness parameters compared to baseline/placebo, suggesting an overall improvement in skin condition with astaxanthin supplementation.

Astaxanthin (AstaReal®)
–21.7% reduction in oxidative stress | Improved desquamation and skin surface quality
Chalyk NE, et al. Nutr Res. 2018;48:40–48.
Open-label intervention study in 31 middle-aged men and women (>40 years) who took 4 mg of astaxanthin daily for 4 weeks. Results showed a reduction in plasma malondialdehyde (marker of oxidative stress) by 11.2% on day 15 and by 21.7% on day 29 compared to baseline, along with a significant reduction in corneocyte desquamation and microbial presence in residual skin surface components, suggesting improved skin surface morphology and reduced oxidative stress with continued astaxanthin intake.

Lutemax® 2020 (Lutein & Zeaxanthin)
Improved macular pigment and visual performance | Reduced eye strain, headaches and improved sleep quality
Stringham JM, et al. Invest Ophthalmol Vis Sci. 2017;58(9):3879–3888.
Randomized, double-blind, placebo-controlled study in healthy adults who were administered 24mg of macular carotenoids from Lutemax® 2020 daily for 6 months. Results showed a significant increase in macular pigment optical density compared to placebo, significant improvements in contrast sensitivity, glare sensitivity and recovery from light stress and visual performance in bright light conditions, along with a significant reduction in eye strain, eye fatigue and headache frequency while improving overall sleep quality.

Lutemax® 2020 (Lutein & Zeaxanthin)
Improved skin tone and luminosity | Increased light protection and skin brightening
Juturu V, et al. Clin Cosmet Investig Dermatol. 2016;9:325–332.
Randomized, double-blind, placebo-controlled study of 46 healthy adults (18–45 years, Fitzpatrick skin types II–IV) who received 10mg lutein + 2mg zeaxanthin isomers (Lutemax® 2020) daily for 12 weeks. Results showed significant improvements in overall skin tone, increased skin luminosity, decreased skin laxity, increased individual typological angle (indicating measurable skin lightening), increased minimal erythemal dose (better UV light protection), and improved skin firmness and elastic recovery compared to placebo.

LycoBeads® (Tomato Lycopene Complex)
Reduced bone resorption markers and supported bone formation in postmenopausal women
Meeta M, et al. J Midlife Health. 2022;13(1):50–56.
Randomized, double-blind, placebo-controlled study at 21 centers in India with 100 healthy postmenopausal women who were given 8 mg LycoRed (antioxidant power equivalent to 24 mg lycopene) or placebo daily for 6 months. Supplementation resulted in a significant increase in serum lycopene compared to placebo, a favorable directional change with increased bone formation marker P1NP and a reduction in bone resorption marker β-CTx, and a higher proportion of women achieving a significant reduction in β-CTx (46% versus 33% on placebo), in addition to a significant reduction in hs-CRP and no supplement-related adverse events.

LycoBeads® (Tomato Lycopene Complex)
Reduced oxidative stress and bone resorption in postmenopausal women
Mackinnon ES, et al. Osteoporos Int. 2011;22(4):1091–1101.
Randomized, double-blind, placebo-controlled study in postmenopausal women who received lycopene or placebo for 4 months. The results showed a significant reduction in oxidative stress parameters and serum N-telopeptide, a marker of bone resorption, compared to placebo, supporting the protective effect of lycopene against bone loss in postmenopausal women.

LycoBeads® (Tomato Lycopene Complex)
Protection against UV-induced light ageing of human skin
Grether-Beck S, et al. Br J Dermatol. 2017;176(5):1231–1240.
Double-blind, randomized, placebo-controlled, crossover study in 65 healthy adults who received a lycopene-rich tomato nutrient complex or a placebo for 12 weeks. After supplementation, UV-irradiated skin showed complete prevention of UV-induced increases in HO-1, ICAM-1 and MMP-1 mRNA expression compared to placebo, demonstrating molecular protection of human skin against UV-induced oxidative stress, inflammation and collagen degradation associated with photoaging.